Get the Stockscreener App
0.5513
3.28%
-0.0187
Alps Group Inc stock is traded at $0.5513, with a volume of 51,902.
It is down -3.28% in the last 24 hours and down -18.99% over the past month.
ALPS Group Inc is a fully integrated platform encompassing biotechnology research, medical, and wellness services specializing in predictive, precision and preventive health management. It aims to provide its clientele with access to DNA and mRNA sequencing, cellular therapy, as well as wellness and anti-aging products and services.
See More
Previous Close:
$0.57
Open:
$0.5515
24h Volume:
51,902
Relative Volume:
0.60
Market Cap:
$91.74M
Revenue:
-
Net Income/Loss:
$-2.73M
P/E Ratio:
-0.7588
EPS:
-0.7265
Net Cash Flow:
$-962.40K
1W Performance:
-6.40%
1M Performance:
-18.99%
6M Performance:
-43.90%
1Y Performance:
+286.88%
1-Day Range:
$0.55
$0.565
1-Week Range:
$0.55
$0.60
52-Week Range:
$0.55
$2.90
Alps Group Inc Stock (ALPS) Company Profile
Compare ALPS vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALPS
Alps Group Inc
|
0.5513 | 91.74M | 0 | -2.73M | -962.40K | -0.7265 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Alps Group Inc Stock (ALPS) Latest News
Malaysian firm sets sights on PHL healthcare market - BusinessMirror
Why did Alps Group (ALPS) stock jump over 15% after hours? - MSN
ALPS PE Ratio & Valuation, Is ALPS Overvalued - Intellectia AI
Level 3 Construction Named GC for Rebrand and Conversion of Four - The National Law Review
M c Dermott Will & Schulte advises ALPS Insurance on acquisition of Ohio Bar Liability Insurance Company - McDermott Will & Schulte
Enterprise value to revenue forward of Alps Group Inc. – OTC:ALPWF - TradingView
Price to earnings forward of Alps Group Inc. – OTC:ALPWF - TradingView
Enterprise value to EBITDA forward of Alps Group Inc. – OTC:ALPWF - TradingView
Price to sales forward of Alps Group Inc. – OTC:ALPWF - TradingView
Price to book forward of Alps Group Inc. – OTC:ALPWF - TradingView
Alps Group Inc (ALPS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Price to sales forward of ALPS Group Inc – NASDAQ:ALPS - TradingView
Price to book forward of ALPS Group Inc – NASDAQ:ALPS - TradingView
Enterprise value to EBITDA forward of ALPS Group Inc – NASDAQ:ALPS - TradingView
Alps Group Inc (ALPS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
ALPS Group Inc (ALPS) Holds Steady at $0.65 as Traders Weigh Key LevelsETF Creation Redemption - dars.gov.et
Why Leifras Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket - Benzinga
Alps Group Inc Launches Patient-Derived Organoid Program to Advance Personalized Cancer Care in Southeast Asia - Sahm
Why Did Alps Group (ALPS) Stock Jump Over 15% After Hours? - Benzinga
Form 6K Alps Group Inc For: 23 June By Investing.com - Investing.com South Africa
Alps Group Launches Patient-Derived Organoid Program to Drive Precision Cancer Care in Southeast Asia - TipRanks
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Alps Group (Nasdaq: ALPS) launches patient-derived organoid cancer program - Stock Titan
Alps Group enters precision oncology via PDO research pact - Investing.com UK
Alps Group enters precision oncology via PDO research pact By Investing.com - Investing.com Nigeria
Alps Group Inc Expands Into Patient-Derived Organoid Technology Through Research and Collaboration Agreement with Axiocell Biotech Executive Director - Quiver Quantitative
Enterprise Products Partners L.P. $EPD Shares Sold by River Road Asset Management LLC - MarketBeat
Alps Group Inc (ALPS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Alps Group Inc (ALPS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Alps Group Inc (ALPS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Alps Group Inc (ALPS) Institutional Confidence - TradingKey
Alps Group Inc (ALPS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Alps Group Inc (ALPS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Alps Group Inc (ALPS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
SVC Q1 2026 Earnings: Massive EPS Miss Amid Operational HeadwindsEarnings Revision Report - newsline.com
Alps Advisors Inc. Purchases 890,193 Shares of Genesis Energy, L.P. $GEL - MarketBeat
Alps Advisors Inc. Buys 1,050,952 Shares of Hewlett Packard Enterprise Company $HPE - MarketBeat
Alps Advisors Inc. Buys 22,294 Shares of Darden Restaurants, Inc. $DRI - MarketBeat
Alps Advisors Inc. Boosts Holdings in T-Mobile US, Inc. $TMUS - MarketBeat
Alps Advisors Inc. Raises Holdings in Kenvue Inc. $KVUE - MarketBeat
Alps Advisors Inc. Has $24.41 Million Stake in Targa Resources, Inc. $TRGP - MarketBeat
Alps Advisors Inc. Acquires Shares of 373,406 Microchip Technology Incorporated $MCHP - MarketBeat
Alps Advisors Inc. Has $24.80 Million Stock Position in Cheniere Energy, Inc. $LNG - MarketBeat
Alps Advisors Inc. Reduces Position in Bristol Myers Squibb Company $BMY - MarketBeat
Alps Advisors Inc. Grows Position in Altria Group, Inc. $MO - MarketBeat
Alps Advisors Inc. Has $23.92 Million Stock Holdings in Ford Motor Company $F - MarketBeat
Alps Advisors Inc. Boosts Stake in Kinder Morgan, Inc. $KMI - MarketBeat
Genuine Parts Company $GPC Shares Bought by Alps Advisors Inc. - MarketBeat
ALPS Group Inc (ALPS) Holds Steady at $0.70 as Support and Resistance Levels TightenDiamond Pattern - newsline.com
Alps Group Wins ISO 15189:2022 Accreditation for Whole Genome Sequencing at MyGenome - TipRanks
MyGenome receives clinical accreditation for genome sequencing - Investing.com UK
Alps Group Inc Stock (ALPS) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.64%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):